Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation episode artwork

EPISODE · Mar 18, 2016 · 21 MIN

Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation

from Medical Breakthroughs from Penn Medicine

Host: Barnett Mennen, MD Guest: Maarouf Hoteit, MD Hepatocellular carcinoma is one of the top ten causes of cancer death in the United States, and is the most rapidly increasing cause of cancer death in men. What's more, incidence rates are on the rise. For these reasons, understanding the nuances of early liver cancer detection, and treating underlying liver diseases prior to cancer development, have been more urgently needed. Joining Dr. Barry Mennen to discuss diagnostic, medical, and surgical priorities for managing hepatocellular carcinoma is Dr. Maarouf Hoteit, Assistant Professor of Clinical Medicine, Director of the Multidisciplinary Liver Tumor Clinic, and Program Director of the Transplant Hepatology Fellowship at the University of Pennsylvania Perelman School of Medicine.

Episode metadata supplied by the publisher feed · Published Mar 18, 2016

Embed this episode

NOW PLAYING

Hepatocellular Carcinoma: Clinical Priorities from Detection to Liver Transplantation

0:00 21:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Breakthroughs from Penn Medicine?

This episode is 21 minutes long.

When was this Medical Breakthroughs from Penn Medicine episode published?

This episode was published on March 18, 2016.

Can I download this Medical Breakthroughs from Penn Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!